Search / Trial NCT06226779

Baduanjin Versus Brisk Walking for Cognition in Schizophrenia

Launched by CHANG GUNG MEMORIAL HOSPITAL · Jan 18, 2024

Trial Information

Current as of October 03, 2024

Recruiting

Keywords

Schizophrenia, Mindful Exercise, Exercise, Cognition

Description

Cognitive function deficits are core features in patients with schizophrenia. These deficits need active intervention to prevent functional decline. Baduanjin and brisk walking show promise as interventions in patients with schizophrenia. This study investigated the effects of Baduanjin exercise versus brisk walking in patients with schizophrenia. This study will be a single-blind, 3-arm, parallel, randomized controlled trial. A total of 120 patients with schizophrenia will be enrolled and randomly assigned to the Baduanjin group, brisk walking group or control group. The intervention gro...

Gender

ALL

Eligibility criteria

  • Inclusion Criteria:
  • 1. Having a diagnosis of schizophrenia according to the DSM-5.
  • 2. Who will be above 20-65 years of age .
  • 3. Having a stable mental status without shift in medication and keep in same dose for at least one month.
  • 4. Being able to walk independently for 50 meters.
  • Exclusion Criteria:
  • 1. Serious physical conditions that will impede participation, such as cardiovascular disease, musculoskeletal disease or pulmonary system disease.
  • 2. Visual or auditory impairment that precludes completion of assessment.
  • 3. Acute psychosis requiring hospitalization.
  • 4. Presence of severe withdrawal or profound cognitive disability that cause difficulties in following instructions.

About Sponsor

The National Institute of Allergy and Infectious Diseases (NIAID, /ˈnaɪ.æd/) is one of the 27 institutes and centers that make up the National Institutes of Health (NIH), an agency of the United States Department of Health and Human Services (HHS). NIAID's mission is to conduct basic and applied research to better understand, treat, and prevent infectious, immunologic, and allergic diseases.

Contacts

JC

Jennifer Cobb

Immunology at National Institute of Allergy and Infectious Diseases (NIAID)

Locations

Kaohsiung, , Taiwan

People applied

Timeline

First submit

Trial launched

Trial updated

Estimated completion

Not reported

Discussion 0